dc.contributor.author | Donaghy, PC | |
dc.contributor.author | Ciafone, J | |
dc.contributor.author | Durcan, R | |
dc.contributor.author | Hamilton, CA | |
dc.contributor.author | Barker, S | |
dc.contributor.author | Lloyd, J | |
dc.contributor.author | Firbank, M | |
dc.contributor.author | Allan, LM | |
dc.contributor.author | O'Brien, JT | |
dc.contributor.author | Taylor, J-P | |
dc.contributor.author | Thomas, AJ | |
dc.date.accessioned | 2020-08-04T15:01:32Z | |
dc.date.issued | 2020-08-25 | |
dc.description.abstract | Background
Recently published diagnostic criteria for mild cognitive impairment with Lewy bodies (MCI-LB)
include five neuropsychiatric supportive features (non-visual hallucinations, systematised delusions,
apathy, anxiety and depression). We have previously demonstrated that the presence of two or
more of these symptoms differentiates MCI-LB from MCI due to Alzheimer’s disease (MCI-AD) with a
likelihood ratio >4. The aim of this study was to replicate the findings in an independent cohort.
Methods
Participants ≥60 years old with MCI were recruited. Each participant had a detailed clinical, cognitive
and imaging assessment including FP-CIT SPECT and cardiac MIBG. The presence of neuropsychiatric
supportive symptoms was determined using the neuropsychiatric inventory (NPI). Participants were
classified as MCI-AD, possible MCI-LB and probable MCI-LB based on current diagnostic criteria.
Participants with possible MCI-LB were excluded from further analysis.
Results
Probable MCI-LB (n=28) had higher NPI total and distress scores than MCI-AD (n=30). 59% of MCI-LB
had two or more neuropsychiatric supportive symptoms compared with 9% of MCI-AD (likelihood
ratio 6.5, p<0.001). MCI-LB participants also had significantly greater delayed recall and a lower
Trails A:Trails B ratio than MCI-AD.
Conclusions
5
MCI-LB is associated with significantly greater neuropsychiatric symptoms than MCI-AD. The
presence of two or more neuropsychiatric supportive symptoms as defined by MCI-LB diagnostic
criteria is highly specific and moderately sensitive for a diagnosis of MCI-LB. The cognitive profile of
MCI-LB differs from MCI-AD, with greater executive and lesser memory impairment, but these
differences are not sufficient to differentiate MCI-LB from MCI-AD. | en_GB |
dc.description.sponsorship | Alzheimer’s Research UK | en_GB |
dc.description.sponsorship | National Institute for Health Research (NIHR) | en_GB |
dc.identifier.citation | Published online 25 August 2020 | |
dc.identifier.doi | 10.1017/S003329172000290 | |
dc.identifier.grantnumber | ARUK-PG3026-13 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/122316 | |
dc.language.iso | en | en_GB |
dc.publisher | Cambridge University Press (CUP) | en_GB |
dc.rights.embargoreason | Under embargo until 25 February 2021 in compliance with publisher policy | en_GB |
dc.rights | © The Author(s), 2020. Published by Cambridge University Press | |
dc.title | Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2020-08-04T15:01:32Z | |
dc.identifier.issn | 0033-2917 | |
dc.description | This is the author accepted manuscript. The final version is available from Cambridge University Press via the DOI in this record | en_GB |
dc.identifier.journal | Psychological Medicine | en_GB |
dc.rights.uri | http://www.rioxx.net/licenses/all-rights-reserved | en_GB |
dcterms.dateAccepted | 2020-07-28 | |
rioxxterms.version | AM | en_GB |
rioxxterms.licenseref.startdate | 2020-07-28 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2020-08-04T14:39:18Z | |
refterms.versionFCD | AM | |
refterms.dateFOA | 2021-02-25T00:00:00Z | |
refterms.panel | A | en_GB |